Skip to main content

Published locations for TRAIN-2: Anthracyclines added toxicity, with no increased efficacy, in HER2+ breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. TRAIN-2: Anthracyclines added toxicity, with no increased efficacy, in HER2+ breast cancer

User login

  • Reset your password
  • /content/train-2-anthracyclines-added-toxicity-no-increased-efficacy-her2-breast-cancer
  • /internalmedicinenews/article/223040/breast-cancer/train-2-anthracyclines-added-toxicity-no-increased
  • /obgynnews/article/223040/breast-cancer/train-2-anthracyclines-added-toxicity-no-increased-efficacy
  • /oncologypractice/article/223040/breast-cancer/train-2-anthracyclines-added-toxicity-no-increased
  • /obgyn/article/223040/breast-cancer/train-2-anthracyclines-added-toxicity-no-increased-efficacy-her2
  • /hematology-oncology/article/223040/breast-cancer/train-2-anthracyclines-added-toxicity-no-increased
  • /internalmedicine/article/223040/breast-cancer/train-2-anthracyclines-added-toxicity-no-increased
  • /breast-cancer-icymi/article/223040/breast-cancer/train-2-anthracyclines-added-toxicity-no-increased